Elisabetta Morello
Turin, 10125, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors -1α and -2α in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets.
Journal: Cancers
Published: November 04, 2019
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD).
Journal: Free radical biology & medicine
Published: May 24, 2018
Hypoxia-inducible factor 2α drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine-rich glycoprotein.
Journal: Hepatology (Baltimore, Md.)
Published: August 04, 2017
Serpinb3 is overexpressed in the liver in presence of iron overload.
Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research
Published: July 02, 2017
SerpinB3 Promotes Pro-fibrogenic Responses in Activated Hepatic Stellate Cells.
Journal: Scientific reports
Published: August 03, 2016
Hepatic myofibroblasts and fibrogenic progression of chronic liver diseases.
Journal: Histology and histopathology
Published: April 22, 2015
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity.
Journal: Scientific reports
Published: April 08, 2015
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells.
Journal: Oncotarget
Published: September 01, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026